Human papillomavirus related cervical cancer and anticipated vaccination challenges in Ethiopia

Abstract

Cervical cancer is the leading cause of cancer deaths among women in Ethiopia. This may be due to the high prevalence of high-risk human papillomavirus (HR-HPV) genotypes in the population. So far, few studies have been done that showed the presence of HR-HPV genotypes. The HR-HPV-16, -18, -52, -56, -31 and -58 were the most common genotypes reported in Ethiopia. The introduction of HPV vaccines in Ethiopia is likely to go a long way in reducing cervical cancer deaths. However, there are few challenges to the introduction of the vaccines. The target population for HPV vaccination is at the moment not well-defined. Besides, the current HPV vaccines confer only type-specific (HPV-16 and -18) immunity, leaving a small proportion of Ethiopian women unprotected against other HR-HPV genotypes such as 52, 56, 31 and 58. Thus, future HPV vaccines such as the nanovalent vaccine may be more useful to Ethiopia as they will protect women against more genotypes.

Keywords: Cervical cancer, Human papillomavirus,Vaccination challenges, Ethiopia.

 

Keywords:

Cervical cancer Humanpapillomavirus Vaccination challenges Ethiopia
Gebremariam, T. T. (2016). Human papillomavirus related cervical cancer and anticipated vaccination challenges in Ethiopia. International Journal of Health Sciences, 10(1). Retrieved from https://pub.qu.edu.sa/index.php/journal/article/view/1380
Copyright and license info is not available

Author Biography

Tewelde Tesfaye Gebremariam, Mekelle University, College of Health Sciences, Institute of Biomedical Sciences Sciences, Mekelle, Ethiopia

Lecturer

Department of Medical Microbiology and Immunology, Institute of Biomedical Sciences, College of Health Sciences, Mekelle University